Good prospects for the future.
You can read about our progress and milestones, about our expansions and our experts, about our engagement and exchanges, in brief: about everything that motivates us.

Press Releases

  1. Heidelberg, April 29, 2022

    Clinical Studies Demonstrate that Patients with Focal Epilepsies Benefit from the Technologically Innovative Therapy EASEE®

    Prof. Andreas Schulze-Bonhage, MD, Head of the Epilepsy Center at the University Hospital Freiburg, who is responsible for the multi-center study on the efficacy of EASEE®, present […]

    Read more
  2. Heidelberg, February 21, 2022

    Minimally Invasive Epilepsy Treatment EASEE® Receives FDA Breakthrough Device Designation

    Heidelberg-based Precisis GmbH has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its EASEE® brain stimulator. FDA’s breakthrough dev […]

    Read more
  3. Heidelberg, October 21, 2021

    Precisis concludes funding round of €20 million for its bioelectric brain stimulation system

    Today, Precisis GmbH, based in Heidelberg, announced that it has successfully concluded a funding round of €20 million with Cochlear Limited. Precisis is a medical technology compa […]

    Read more